col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


104 Results       Page 1

 [1] 
American Chemical Society: Journal of Proteome Research
  original article Date Title Authors   All Authors
1 [GO] 2025―Jan―28 Investigation of Immunoreactivity Profiles and Epitope Landscape in Divergent COVID-19 Trajectories and SARS-CoV-2 Variants Surbhi Bihani, Arka Ray, Dhanush Borishetty, Chaitanya Tuckley, Akanksha Salkar, Arup Acharjee, et al. (+6)
2 [GO] 2025―Jan―13 4D-DIA Proteomics Uncovers New Insights into Host Salivary Response Following SARS-CoV-2 Omicron Infection Iasmim Lopes de Lima, Thais Regiani Cataldi, Carlos Brites, Mônica Teresa Veneziano Labate, Sara Nunes Vaz, Felice Deminco, et al. (+3)
3 [GO] 2025―Jan―08 Assessment of Humoral Response at SARS-CoV-2 Infection by Multipronged Functional Proteomics Approaches Pablo Juanes-Velasco, Juan Carlos Pérez-Arévalo, Carlota Arias-Hidalgo, Ana Nuño-Soriano, Alicia Landeira-Viñuela, Fernando Corrales, et al. (+9)
4 [GO] 2024―Nov―27 Dynamic Cellular Proteome Remodeling during SARS-CoV-2 Infection. Identification of Plasma Protein Readouts Fátima Milhano dos Santos, Jorge Vindel-Alfageme, Sergio Ciordia, Victoria Castro, Irene Orera, Urtzi Garaigorta, et al. (+2)
5 [GO] 2024―Oct―01 Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19 Jean-Marie Michot, Vito Dozio, Julien Rohmer, Fanny Pommeret, Mathilde Roumier, Haochen Yu, et al. (+24)
6 [GO] 2024―Aug―19 Valuable Contributions and Lessons Learned from Proteomics and Metabolomics Studies of COVID-19 Bhaswati Chatterjee, Suman S. Thakur
7 [GO] 2024―Aug―19 Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort Bradley Ward, Sébastien Pyr dit Ruys, Jean-Luc Balligand, Leïla Belkhir, Patrice D. Cani, Jean-François Collet, et al. (+10)
8 [GO] 2024―Aug―15 Characterization of the Antibody Response to SARS-CoV-2 Infection in COVID-19 Transplant versus Nontransplant Recipients by Ig-MS Benjamin J. Des Soye, Rafael D. Melani, Michael A. R. Hollas, Jiana Duan, Steven M. Patrie, Troy D. Fisher, et al. (+6)
9 [GO] 2024―Jun―05 Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19 Qiaoyun Gong, Mingshui Fu, Jingyi Wang, Shuzhi Zhao, Haiyan Wang
10 [GO] 2024―Apr―11 Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization Ran Zhang, Lan Huang, Xiaohan Zhang, Yuanling Yu, Te Liang, Hongye Wang, et al. (+6)
11 [GO] 2024―Apr―03 Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients Using a Multiplatform Mass Spectrometry-Based Metabolomics Approach Sara Martínez, Oihane E. Albóniga, María Rosa López-Huertas, Ana Gradillas, Coral Barbas
12 [GO] 2024―Mar―27 Combinatorial Approach with Mass Spectrometry and Lectin Microarray Dissected Site-Specific Glycostem and Glycoleaf Features of the Virion-Derived Spike Protein of Ancestral and γ Variant SARS-CoV-2 Strains Takahiro Hiono, Hiroaki Sakaue, Azusa Tomioka, Hiroyuki Kaji, Michihito Sasaki, Yasuko Orba, et al. (+2)
13 [GO] 2024―Mar―14 Cross-Validation of Metabolic Phenotypes in SARS-CoV-2 Infected Subpopulations Using Targeted Liquid Chromatography-Mass Spectrometry (LC-MS) Luke Whiley, Nathan G. Lawler, Annie Xu Zeng, Alex Lee, Sung-Tong Chin, Maider Bizkarguenaga, et al. (+7)
14 [GO] 2024―Feb―04 Integrative Molecular Structure Elucidation and Construction of an Extended Metabolic Pathway Associated with an Ancient Innate Immune Response in COVID-19 Patients Samuele Sala, Philipp Nitschke, Reika Masuda, Nicola Gray, Nathan G. Lawler, James M. Wood, et al. (+22)
15 [GO] 2023―Dec―03 Defining Distinct RNA-Protein Interactomes of SARS-CoV-2 Genomic and Subgenomic RNAs Isabella T. Whitworth, Rachel A. Knoener, Maritza Puray-Chavez, Peter Halfmann, Sofia Romero, M’bark Baddouh, et al. (+5)
16 [GO] 2023―Dec―01 Expression of SARS-CoV-2 Nonstructural Proteins 3 and 4 Can Tune the Unfolded Protein Response in Cell Culture Jonathan P. Davies, Athira Sivadas, Katherine R. Keller, Brynn K. Roman, Richard J.H. Wojcikiewicz, Lars Plate
17 [GO] 2023―Nov―08 Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein Casimir Bamberger, Sandra Pankow, Salvador Martínez-Bartolomé, Jolene K. Diedrich, Robin S. K. Park, John R. Yates
18 [GO] 2023―Aug―30 Determining Site-Specific Glycan Profiles of Recombinant SARS-CoV-2 Spike Proteins from Multiple Sources Meghan C. Burke, Yi Liu, Concepcion Remoroza, Yuri A. Mirokhin, Sergey L. Sheetlin, Dmitrii V. Tchekhovskoi, et al. (+3)
19 [GO] 2023―Aug―27 Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals Ethan J. Fritch, Angie L. Mordant, Thomas S.K. Gilbert, Carrow I. Wells, Xuan Yang, Natalie K. Barker, et al. (+12)
20 [GO] 2023―Aug―09 COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19 Fangfei Zhang, Augustin Luna, Tingting Tan, Yingdan Chen, Chris Sander, Tiannan Guo
21 [GO] 2023―Jul―14 Metaproteomic Analysis of Nasopharyngeal Swab Samples to Identify Microbial Peptides in COVID-19 Patients Surbhi Bihani, Aryan Gupta, Subina Mehta, Andrew T. Rajczewski, James Johnson, Dhanush Borishetty, et al. (+3)
22 [GO] 2023―May―11 Metabolic Adaptations Correlated with Antibody Response after Immunization with Inactivated SARS-CoV-2 in Brazilian Subjects Jeane de Souza Nogueira, Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, Ana Paula Valente, Marcos C. Gama-Almeida, Tatiana El-Bacha, et al. (+8)
23 [GO] 2023―Apr―24 Detection of Mutant Peptides of SARS-CoV-2 Variants by LC/MS in the DDA Approach Using an In-House Database Sakshi Rajoria, Ankit Halder, Ishita Tarnekar, Pracheta Pal, Prakhar Bansal, Sanjeeva Srivastava
24 [GO] 2023―Apr―10 CoVe-Tracker: An Interactive SARS-CoV-2 Pan Proteome Evolution Tracker Chakkarai Sathyaseelan, Murali Aadhitya Magateshvaren Saras, L. Ponoop Prasad Patro, Patil Pranita Uttamrao, Thenmalarchelvi Rathinavelan
25 [GO] 2022―Nov―07 Divergent Antibody Repertoires Found for Omicron versus Wuhan SARS-CoV-2 Strains Using Ig-MS Eleonora Forte, Benjamin J. Des Soye, Rafael D. Melani, Michael A. R. Hollas, Jared O. Kafader, Beverly E. Sha, et al. (+2)
26 [GO] 2022―Sep―15 Evaluation of Variant-Specific Peptides for Detection of SARS-CoV-2 Variants of Concern Kantaphon Suddhapas, M. Hannah Choi, Michael R. Shortreed, AaronT. Timperman
27 [GO] 2022―Jul―28 Protein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain Cecilia Lindskog, Loren Méar, Johan Virhammar, David Fällmar, Eva Kumlien, Göran Hesselager, et al. (+2)
28 [GO] 2022―Jul―26 MALDI(+) FT-ICR Mass Spectrometry (MS) Combined with Machine Learning toward Saliva-Based Diagnostic Screening for COVID-19 Camila M. de Almeida, Larissa C. Motta, Gabriely S. Folli, Wena D. Marcarini, Camila A. Costa, Ana C. S. Vilela, et al. (+11)
29 [GO] 2022―Jul―05 MALDI-TOF Mass Spectrometric Detection of SARS-CoV-2 Using Cellulose Sulfate Ester Enrichment and Hot Acid Treatment Dapeng Chen, Wayne A. Bryden, Catherine Fenselau, Michael McLoughlin, Caroline R. Haddaway, Alese P. Devin, et al. (+6)
30 [GO] 2022―Jun―08 1H qNMR-Based Metabolomics Discrimination of Covid-19 Severity Banny S. B. Correia, Vinicius G. Ferreira, Priscila M. F. D. Piagge, Mariana B. Almeida, Nilson A. Assunção, Joyce R. S. Raimundo, et al. (+3)
31 [GO] 2022―Jun―02 Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry Michelle V. Gadush, Giuseppe A. Sautto, Hamssika Chandrasekaran, Alena Bensussan, Ted M. Ross, Gregory C. Ippolito, Maria D. Person
32 [GO] 2022―Feb―10 Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19 Yassene Mohammed, David R. Goodlett, Matthew P. Cheng, Donald C. Vinh, Todd C. Lee, Allison Mcgeer, et al. (+21)
33 [GO] 2022―Feb―10 Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2 Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
34 [GO] 2022―Feb―08 Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis Oihane E. Albóniga, Daniel Jiménez, Matilde Sánchez-Conde, Pilar Vizcarra, Raquel Ron, Sabina Herrera, et al. (+5)
35 [GO] 2022―Jan―04 Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV Marica Grossegesse, Daniel Bourquain, Markus Neumann, Lars Schaade, Jessica Schulze, Christin Mache, et al. (+3)
36 [GO] 2021―Dec―08 Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire Rafael D. Melani, Benjamin J. Des Soye, Jared O. Kafader, Eleonora Forte, Michael Hollas, Voislav Blagojevic, et al. (+20)
37 [GO] 2021―Dec―03 A Flickering Light at the End of the Pandemic Tunnel Christopher M. Overall
38 [GO] 2021―Nov―16 Potential Use of Serum Proteomics for Monitoring COVID-19 Progression to Complement RT-PCR Detection Ying Zhang, Xue Cai, Weigang Ge, Donglian Wang, Guangjun Zhu, Liujia Qian, et al. (+21)
39 [GO] 2021―Nov―15 Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides Anthony Maus, Santosh Renuse, Jennifer Kemp, Anil K. Madugundu, Patrick M. Vanderboom, Joseph Blommel, et al. (+6)
40 [GO] 2021―Sep―22 Discovery Proteomics for COVID-19: Where We Are Now Angela McArdle, Kirstin E. Washington, Blandine Chazarin Orgel, Aleksandra Binek, Danica-Mae Manalo, Alejandro Rivas, et al. (+6)
41 [GO] 2021―Aug―25 Inactivation of Coronaviruses during Sample Preparation for Proteomics Experiments Marica Grossegesse, Paula Leupold, Joerg Doellinger, Lars Schaade, Andreas Nitsche
42 [GO] 2021―Aug―11 A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients Kruthi Suvarna, Akanksha Salkar, Viswanthram Palanivel, Renuka Bankar, Nirjhar Banerjee, Medha Gayathri J Pai, et al. (+7)
43 [GO] 2021―Aug―11 Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain Robert A. D’Ippolito, Matthew R. Drew, Jennifer Mehalko, Kelly Snead, Vanessa Wall, Zoe Putman, et al. (+2)
44 [GO] 2021―Aug―09 Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 Byeong Gwan Cho, Sakshi Gautam, Wenjing Peng, Yifan Huang, Mona Goli, Yehia Mechref
45 [GO] 2021―Jul―22 DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients Dong-Gi Mun, Patrick M. Vanderboom, Anil K. Madugundu, Kishore Garapati, Sandip Chavan, Jane A. Peterson, et al. (+2)
46 [GO] 2021―Jul―12 Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts Reika Masuda, Samantha Lodge, Philipp Nitschke, Manfred Spraul, Hartmut Schaefer, Sze-How Bong, et al. (+12)
47 [GO] 2021―Jun―28 Genetic Variability of the SARS-CoV-2 Pocketome Setayesh Yazdani, Nicola De Maio, Yining Ding, Vijay Shahani, Nick Goldman, Matthieu Schapira
48 [GO] 2021―Jun―03 Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response Sandip Chavan, Kiran K. Mangalaparthi, Smrita Singh, Santosh Renuse, Patrick M. Vanderboom, Anil Kumar Madugundu, et al. (+8)
49 [GO] 2021―Jun―03 Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage Yang Chen, Hangping Yao, Nan Zhang, Jie Wu, Shuaixin Gao, Jiangtao Guo, et al. (+6)
50 [GO] 2021―May―19 Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome Elaine Holmes, Julien Wist, Reika Masuda, Samantha Lodge, Philipp Nitschke, Torben Kimhofer, et al. (+21)
51 [GO] 2021―May―05 Correction to “Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection” Torben Kimhofer, Samantha Lodge, Luke Whiley, Nicola Gray, Ruey Leng Loo, Nathan G. Lawler, et al. (+10)
52 [GO] 2021―Apr―16 Identification and Characterization of Species-Specific Severe Acute Respiratory Syndrome Coronavirus 2 Physicochemical Properties Srinivasulu Yerukala Sathipati, Shinn-Ying Ho
53 [GO] 2021―Mar―17 Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses Nathan G. Lawler, Nicola Gray, Torben Kimhofer, Berin Boughton, Melvin Gay, Rongchang Yang, et al. (+13)
54 [GO] 2021―Mar―08 A SARS-CoV-2 Peptide Spectral Library Enables Rapid, Sensitive Identification of Virus Peptides in Complex Biological Samples Jonathan R. St-Germain, Audrey Astori, Brian Raught
55 [GO] 2021―Mar―05 Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis Huan Zhang, Huanying Zheng, Jinying Zhu, Qiao Dong, Jin Wang, Huahao Fan, et al. (+7)
56 [GO] 2021―Feb―22 Applications of Protein Secondary Structure Algorithms in SARS-CoV-2 Research Alibek Kruglikov, Mohan Rakesh, Yulong Wei, Xuhua Xia
57 [GO] 2021―Feb―19 Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2 Wout Bittremieux, Charlotte Adams, Kris Laukens, Pieter C. Dorrestein, Nuno Bandeira
58 [GO] 2021―Feb―08 Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses Sheetal Tushir, Sathisha Kamanna, Sujith S. Nath, Aishwarya Bhat, Steffimol Rose, Advait R. Aithal, Utpal Tatu
59 [GO] 2021―Jan―26 Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins Justyna Saadi, Saoussen Oueslati, Laurent Bellanger, Fabrice Gallais, Laurent Dortet, Anne-Marie Roque-Afonso, et al. (+4)
60 [GO] 2021―Jan―23 Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers Samantha Lodge, Philipp Nitschke, Ruey Leng Loo, Torben Kimhofer, Sze-How Bong, Toby Richards, et al. (+6)
61 [GO] 2021―Jan―21 ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2 Saroj Kumar Panda, Parth Sarthi Sen Gupta, Satyaranjan Biswal, Abhik Kumar Ray, Malay Kumar Rana
62 [GO] 2021―Jan―19 Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology Paige Haas, Monita Muralidharan, Nevan J. Krogan, Robyn M. Kaake, Ruth Hüttenhain
63 [GO] 2021―Jan―13 Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis Shalini Aggarwal, Arup Acharjee, Amrita Mukherjee, Mark S. Baker, Sanjeeva Srivastava
64 [GO] 2021―Jan―13 NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines Samantha Lodge, Philipp Nitschke, Torben Kimhofer, Jerome D. Coudert, Sofina Begum, Sze-How Bong, et al. (+9)
65 [GO] 2021―Jan―04 Metaproteomics Analysis of SARS-CoV-2-Infected Patient Samples Reveals Presence of Potential Coinfecting Microorganisms Peter S. Thuy-Boun, Subina Mehta, Bjoern Gruening, Thomas McGowan, An Nguyen, Andrew T. Rajczewski, et al. (+4)
66 [GO] 2020―Dec―22 Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An In Silico Study Mostafa Jamalan, Ebrahim Barzegari, Fathollah Gholami-Borujeni
67 [GO] 2020―Dec―21 Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication Yi Zhang, Liang V. Tang
68 [GO] 2020―Dec―11 COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions Suvobrata Chakravarty
69 [GO] 2020―Nov―11 Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2 Xiaoqiang Huang, Chengxin Zhang, Robin Pearce, Gilbert S. Omenn, Yang Zhang
70 [GO] 2020―Nov―06 Proteomics and Its Application in Pandemic Diseases Suman S. Thakur
71 [GO] 2020―Oct―29 Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches Antonio Francés-Monerris, Cécilia Hognon, Tom Miclot, Cristina García-Iriepa, Isabel Iriepa, Alessio Terenzi, et al. (+4)
72 [GO] 2020―Oct―26 Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients Tiffany Thomas, Davide Stefanoni, Monika Dzieciatkowska, Aaron Issaian, Travis Nemkov, Ryan C. Hill, et al. (+8)
73 [GO] 2020―Oct―26 Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks Rachel Nadeau, Soroush Shahryari Fard, Amit Scheer, Emily Hashimoto-Roth, Dallas Nygard, Iryna Abramchuk, et al. (+3)
74 [GO] 2020―Oct―22 Targeting Proteases for Treating COVID-19 Binquan Luan, Tien Huynh, Xuemei Cheng, Ganhui Lan, Hao-Ran Wang
75 [GO] 2020―Oct―21 The COVID-19 Pandemic from a Human Genetic Perspective Yue-Miao Zhang, Lin Wang, Xing-Zi Liu, Hong Zhang
76 [GO] 2020―Oct―02 A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
77 [GO] 2020―Oct―02 Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins Gennady M. Verkhivker
78 [GO] 2020―Sep―28 Age-dependent glycomic response to the 2009 pandemic H1N1 influenza virus and its association with disease severity Shuhui Chen, Brian Kasper, Bin Zhang, Lauren P. Lashua, Ted M. Ross, Elodie Ghedin, Lara K. Mahal
79 [GO] 2020―Sep―22 Techniques and strategies for the potential protein-targets discovery and active pharmaceutical molecules screening in Pandemic Hongxin Yu, Chunyan Li, Xing Wang, Jingyi Duan, Na Yang, Lijuan Xie, et al. (+5)
80 [GO] 2020―Sep―15 Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases George Stamatakis, Martina Samiotaki, Anastasia Mpakali, George Panayotou, Efstratios Stratikos
81 [GO] 2020―Sep―11 Computational immune proteomics approach to target COVID-19 Bruno Tilocca, Domenico Britti, Andrea Urbani, Paola Roncada
82 [GO] 2020―Sep―10 Repurposing of FDA-Approved Toremifene to Treat COVID-19 by blocking the spike glycoprotein and NSP14 of SARS-CoV-2 William Martin, Feixiong Cheng
83 [GO] 2020―Sep―08 METATRYP v 2.0: Metaproteomic Least Common Ancestor Analysis for Taxonomic Inference Using Specialized Sequence Assemblies - Standalone Software and Web Servers for Marine Microorganisms and Coronaviruses Jaclyn K Saunders, David A. Gaylord, Noelle A. Held, Nicholas Symmonds, Christopher Dupont, Adam Shepherd, et al. (+2)
84 [GO] 2020―Sep―07 In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins Irene Maffucci, Alessandro Contini
85 [GO] 2020―Sep―05 Rapid response to pandemic threats: immunogenic epitope detection of pandemic pathogens for diagnostics and vaccine development using peptide microarrays Kirsten Heiss, Jasmin Heidepriem, Nico Fischer, Laura K Weber, Christine Dahlke, Thomas Jaenisch, Felix F Loeffler
86 [GO] 2020―Sep―04 ‘A chain only as strong as its weakest link’: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19 Radu Crisan-Dabija, Cristina Alice Pavel, Iolanda Valentina Popa, Andrei Tarus, Alexandru Burlacu
87 [GO] 2020―Aug―27 Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artefact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples Ruey Leng Loo, Samantha Lodge, Torben Kimhofer, Sze-How Bong, Sofina Begum, Luke Whiley, et al. (+9)
88 [GO] 2020―Aug―18 Integrative Modelling of Quantitative Plasma Lipoprotein, Metabolic and Amino Acid Data Reveals a Multi-organ Pathological Signature of SARS-CoV-2 Infection Torben Kimhofer, Samantha Lodge, Luke Whiley, Nicola Gray, Ruey Leng Loo, Nathan G. Lawler, et al. (+10)
89 [GO] 2020―Aug―14 The Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2 Sanja Glisic, Vladimir R. Perovic, Milan Sencanski, Slobodan Paessler, Veljko Veljkovic
90 [GO] 2020―Aug―13 COVID-19: Nanomedicine Uncovers Blood-Clot Mystery Amir Ata Saei, Shahriar Sharifi, Morteza Mahmoudi
91 [GO] 2020―Aug―13 Shell disorder analysis suggests that pangolins offered a window for a silent spread of an attenuated SARS-CoV-2 precursor among humans Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
92 [GO] 2020―Aug―10 Mass Spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via Nucleocapsid N protein Evgeny N. Nikolaev, Maria I. Indeykina, Alexander G. Brzhozovskiy, Anna E. Bugrova, Alexey S. Kononikhin, Natalia L. Starodubtseva, et al. (+4)
93 [GO] 2020―Aug―06 Molecular binding mechanism and pharmacology comparative analysis of noscapine for repurposing against SARS-CoV-2 protease Neeraj Kumar, Damini Sood, Peter J van der Spek, Hari S. Sharma, Ramesh Chandra
94 [GO] 2020―Jul―30 Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 level Angelo D'Alessandro, Tiffany Thomas, Monika Dzieciatkowska, Ryan C Hill, Richard O Francis, Krystalyn E Hudson, et al. (+4)
95 [GO] 2020―Jul―27 Interaction of drugs candidates with various SARS-CoV-2 receptors: an in silico study to combat COVID-19 Romulo O. Barros, Fabio L.C.C. Junior, Wildrimak S. Pereira, Neiva M. N. Oliveira, Ricardo M. Ramos
96 [GO] 2020―Jul―27 Studying the Effects of ACE2 Mutations on Stability, Dynamics and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes Hamid Hadi-Alijanvand, Maryam Rouhani
97 [GO] 2020―Jul―22 Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window Duarte Gouveia, Guylaine Miotello, Fabrice Gallais, Jean-Charles Gaillard, Stéphanie Debroas, Laurent Bellanger, et al. (+5)
98 [GO] 2020―Jul―21 Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19 Minchen Chien, Thomas K. Anderson, Steffen Jockusch, Chuanjuan Tao, Xiaoxu Li, Shiv Kumar, et al. (+3)
99 [GO] 2020―Jul―20 SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes. Olivia Sirpilla, Jacob Bauss, Ruchir Gupta, Adam Underwood, Dinah Qutob, Tom Freeland, et al. (+5)
100 [GO] 2020―Jul―12 Proteomics and informatics for understanding phases and identifying biomarkers in COVID-19 disease Anthony D. Whetton, George W. Preston, Semira Abubeker, Nophar Geifman
101 [GO] 2020―Jul―12 Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning Xiangxiang Zeng, Xiang Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, et al. (+4)
102 [GO] 2020―Jun―22 Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients Christian Ihling, Dirk Tänzler, Sven Hagemann, Astrid Kehlen, Stefan Hüttelmaier, Christian Arlt, Andrea Sinz
103 [GO] 2020―Jun―17 The discovery of a putative allosteric site in SARS-CoV-2 spike protein by an integrated structural/dynamical approach. Luisa Di Paola, Hamid Hadi-Alijanvand, Xingyu Song, Guang Hu, Alessandro Giuliani
104 [GO] 2020―Mar―22 Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1 Chengxin Zhang, Wei Zheng, Xiaoqiang Huang, Eric W. Bell, Xiaogen Zhou, Yang Zhang
 [1] 

104 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec